
China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC
China SXT Pharmaceuticals stock price today
China SXT Pharmaceuticals stock price monthly change
China SXT Pharmaceuticals stock price quarterly change
China SXT Pharmaceuticals stock price yearly change
China SXT Pharmaceuticals key metrics
Market Cap | 1.19M |
Enterprise value | 3.98M |
P/E | -0.13 |
EV/Sales | 0.22 |
EV/EBITDA | -0.40 |
Price/Sales | 0.31 |
Price/Book | 0.38 |
PEG ratio | N/A |
EPS | -735.1 |
Revenue | -14.90M |
EBITDA | -5.93M |
Income | -7.09M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -39.19% |
Oper. margin | -18.25% |
Gross margin | 63.28% |
EBIT margin | -18.25% |
EBITDA margin | 39.84% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeChina SXT Pharmaceuticals stock price history
China SXT Pharmaceuticals stock forecast
China SXT Pharmaceuticals financial statements
Mar 2020 | 5.16M | -10.28M | -199.29% |
---|---|---|---|
Mar 2021 | -9.32M | 5.30M | -56.93% |
Mar 2022 | -11.50M | 2.32M | -20.19% |
Mar 2023 | 763.39K | -4.44M | -581.64% |
Jun 2022 | 22181358 | 7.29M | 32.87% |
---|---|---|---|
Sep 2022 | 22181358 | 7.29M | 32.87% |
Dec 2022 | 29554056 | 14.86M | 50.29% |
Mar 2023 | 29554056 | 14.86M | 50.29% |
Sep 2020 | 0 | -59.60K | 137.24K |
---|---|---|---|
Mar 2021 | -6.40M | -4.17M | 16.16M |
Mar 2022 | -4.82M | 1.58M | 5.35M |
Mar 2023 | 468.36K | -51.61K | 14.01M |
China SXT Pharmaceuticals alternative data
Aug 2023 | 88 |
---|---|
Sep 2023 | 88 |
Oct 2023 | 88 |
Nov 2023 | 88 |
Dec 2023 | 88 |
Jan 2024 | 88 |
Feb 2024 | 88 |
Mar 2024 | 88 |
Apr 2024 | 88 |
May 2024 | 88 |
Jun 2024 | 78 |
Jul 2024 | 78 |
China SXT Pharmaceuticals other data
Insider | Compensation |
---|---|
Dr. Jingzhen Deng (1960) Chief Scientific Officer & Chief Operating Officer | $50,000 |
Mr. Feng Zhou (1992) Chairman & Chief Executive Officer | $50,000 |
-
What's the price of China SXT Pharmaceuticals stock today?
One share of China SXT Pharmaceuticals stock can currently be purchased for approximately $1.57.
-
When is China SXT Pharmaceuticals's next earnings date?
Unfortunately, China SXT Pharmaceuticals's (SXTC) next earnings date is currently unknown.
-
Does China SXT Pharmaceuticals pay dividends?
No, China SXT Pharmaceuticals does not pay dividends.
-
How much money does China SXT Pharmaceuticals make?
China SXT Pharmaceuticals has a market capitalization of 1.19M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 2.19% to 1.93M US dollars.
-
What is China SXT Pharmaceuticals's stock symbol?
China SXT Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "SXTC".
-
What is China SXT Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of China SXT Pharmaceuticals?
Shares of China SXT Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are China SXT Pharmaceuticals's key executives?
China SXT Pharmaceuticals's management team includes the following people:
- Dr. Jingzhen Deng Chief Scientific Officer & Chief Operating Officer(age: 65, pay: $50,000)
- Mr. Feng Zhou Chairman & Chief Executive Officer(age: 33, pay: $50,000)
-
How many employees does China SXT Pharmaceuticals have?
As Jul 2024, China SXT Pharmaceuticals employs 78 workers, which is 11% less then previous quarter.
-
When China SXT Pharmaceuticals went public?
China SXT Pharmaceuticals, Inc. is publicly traded company for more then 6 years since IPO on 4 Jan 2019.
-
What is China SXT Pharmaceuticals's official website?
The official website for China SXT Pharmaceuticals is sxtchina.com.
-
How can i contact China SXT Pharmaceuticals?
China SXT Pharmaceuticals can be reached via phone at +86 523 8629 8290.
China SXT Pharmaceuticals company profile:

China SXT Pharmaceuticals, Inc.
sxtchina.comNASDAQ
75
Drug Manufacturers - Specialty & Generic
Healthcare
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.
Taizhou, 225300
CIK: 0001723980
ISIN: VGG2161P1403
CUSIP: G2161P108